Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2006-09-05
2006-09-05
Mertz, Prema (Department: 1646)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S007100, C435S007200
Reexamination Certificate
active
07101679
ABSTRACT:
The present invention provides for methods and materials for diagnosing and treating neuromyelitis optica (NMO).
REFERENCES:
patent: 4708713 (1987-11-01), Lentz
patent: 5214136 (1993-05-01), Lin et al.
patent: 5218105 (1993-06-01), Cook et al.
patent: 5258503 (1993-11-01), Yokohari et al.
patent: 5386734 (1995-02-01), Pusinelli
patent: 5614192 (1997-03-01), Vandenbark
patent: 5976872 (1999-11-01), Tao et al.
patent: 6066726 (2000-05-01), Farb et al.
patent: 6409696 (2002-06-01), Toavs et al.
patent: 2002/0037273 (2002-03-01), Cummins et al.
Luck, D.N., et al. 1991. Single amino acid substitutuions in recombinant bovine prolactin that markedly reduce its mitogenic activity in Nb2 cell cultures. Mol. Endocrinol. vol. 5(12), p. 1880-1886.
Harlow and Lane (1988) Antibodies, A Laboratory Manual. Cold Spring Harbor Laboratory, Chapter 5, p. 76.
GenBank Accession No. U63622 dated Nov. 22, 1996, Lu et al.
GenBank Accession No. U63623 dated Nov. 22, 1996, Lu et al.
GenBank Accession No. AAG17964 dated Oct. 30, 2000, Lu et al.
GenBank Accession No. AAB26957 dated Nov. 22, 1996, Lu et al.
GenBank Accession No. AAB26958 dated Nov. 22, 1996, Lu et al.
GenBank Accession No. I39178 dated Jun. 20, 2000, Yong et al.
GenBank Accession No. BC022286 dated Jun. 29, 2004, Strausberg et al.
GenBank Accession No. NM—004028 dated Oct. 28, 2004, Huang et al.
GenBank Accession No. NM—001650 dated Oct. 28, 2004, Huang et al.
Haase and Schmidt, “Detection of brain-specific autoantibodies to myelin oligodendrocyte glycoprotein, S100β and myelin basic protein in patients with Devic's neuromyelitis optica,”Neurosci. Lett., 2001, 307(2):131-133.
Habibaghahi, “Anticardiolipin Antibody in Patients with Multiple sclerosis,”Shiraz E-Medical J., 3(3) at http://www.sums.ac.ir/˜semj/vol3/may2002/rACAinMS.htm printed from internet on Feb. 18, 2003.
Jambou et al., “Circulating regulatory anti-T cell receptor antibodies in patients with myasthenia gravis,”J. Clin. Invest., 2003, 112:265-274.
Mackay, “Tolerance and autoimmunity,”British Med. J., 2000, 321:93-96.
Matsumoto et al., “Successful TCR-Based Immunotherapy for Autoimmune Myocarditis with DNA Vaccines After Rapid Identification of Pathogenic TCR,”J. Immunol., 2000, 164:2248-2254.
Miyagishi et al., “Two cases of recurrent optic neuritis (OPN) and acute transverse myelopathy (ATM) with associated anticardiolipin antibodies,”Clin. Neurol., 1992, 32(10):1121-1124, English-language Abstract.
Robin et al., “Anti-Myelin Basic Protein Antibody in Experimental Allergic Optic Neuritis and Encephalomyelitis,”Opthalmic Res., 1985, 17(3):174-180.
Sakuma et al., “Optic-spinal form of multiple sclerosis and anti-thyroid autoantibodies,”J. Neurol., 1999, 246(6):449-453.
Schwartz, “Direct Visualization of Antigen-Specific Cytotoxic T Cells—A New Insight into Immune Defenses,”N. Engl. J. Med., 1998, 339(15):1076-1078.
Sellebjerg et al., “Anti-Myelin Basic Protein and Anti-Proteolipid Protein Antibody-Secreting Cells in the Cerebrospinal Fluid of Patients With Acute Optic Neuritis,”Arch. Neurol., 1994, 51(10):1032-1036.
Soderstrom et al., “Optic neuritis and multiple sclerosis: Anti-MBP and anti-MBP peptide antibody-secreting cells are accumulated in CSF,”Neurology, 1993, 43(6):1215-1222.
Tumani et al., “Acute optic neuritis: combined immunological markers and magnetic resonance imaging predict subsequent development of multiple sclerosis,”J. Neurol. Sci., 1998, 155(1):44-49.
Verkman et al., “Role of water channels in fluid transport studied by phenotype analysis of aquaporin knockout mice,”Exp. Physiol., 2000, 85S:233S-241S.
Kryzer Thomas J.
Lennon Vanda A.
Mayo Foundation for Medical Education and Research
Mertz Prema
LandOfFree
Marker for neuromyelitis optica does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Marker for neuromyelitis optica, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Marker for neuromyelitis optica will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3610466